Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Via Intranasal Administration in Patients With Frontotemporal Dementia
NCT07638813 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Via Intranasal Administration in Patients With Frontotemporal Dementia
- Lead sponsor
- Ruijin Hospital
- Phase
- Phase 1/2
- Overall status
- Not yet recruiting
- Start date
- July 1, 2026
- Completion date
- October 31, 2027
- Enrollment
- 33 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.